To include your compound in the COVID-19 Resource Center, submit it here.

IDEC-152: Phase I

In a U.S. Phase I study of 30

Read the full 81 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE